🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the Safety and Efficacy of Nirsevi...
Status
Completed
Location
Research Site
Start Date
2021-11-24
Trial ID
NCT05110261
Treatments Being Tested
The purpose of this study is to continue evaluating how well the RSV vaccin...
Status
Recruiting
Location
Yale Child Health Research Center
Start Date
2024-10-28
Trial ID
NCT06172660
Treatments Being Tested
Respiratory tract infections caused by respiratory syncytial virus (RSV) ar...
Status
Completed
Location
CHU Bondy - Jean Verdier
Start Date
2023-10-15
Trial ID
NCT06030505
Treatments Being Tested
The goal of this observational study is to explore the impact of a new prev...
Status
Completed
Location
The Canberra Hospital
Start Date
2024-12-01
Trial ID
NCT07177508
Respiratory syncytial virus (RSV) is a leading cause of hospitalizations fo...
Status
Active Not Recruiting
Location
Griffith University
Start Date
2024-04-15
Trial ID
NCT06993753
Among children aged ≤ 6 months included in the ENVIE study, the ENVIE\_anci...
Status
Recruiting
Location
CHI Créteil
Start Date
2024-12-05
Trial ID
NCT07698769
Treatments Being Tested
The Nirse-CL study is a collaborative effort between the Ministry of Health...
Status
Unknown
Location
ISCI
Start Date
2024-04-01
Trial ID
NCT06511687
Treatments Being Tested
RSV (which stands for Respiratory Syncytial Virus) is an infection that cau...
Status
Recruiting
Location
CHD Vendée
Start Date
2026-05-06
Trial ID
NCT07232706
Treatments Being Tested
This study is a randomized, double-blind, placebo/positive control Phase Ia...
Status
Recruiting
Location
Wuhan Jinyintan Hospital
Start Date
2025-08-17
Trial ID
NCT07106918
Treatments Being Tested
Study D5290C00008 is a Phase 2, open-label, uncontrolled, single-dose study...
Status
Completed
Location
Research Site
Start Date
2020-08-19
Trial ID
NCT04484935
Treatments Being Tested